CENTESSA PHARMACEUTICALS PLC (CNTA)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$40.500.00%
Close 2026-06-25 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · CNTA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | — | 15.0 | — | 6.9 | 0.0 | — | — |
| Total Revenues | — | 15.0 | — | 6.9 | 0.0 | — | — |
| Operating Expenses & Income | |||||||
| Operating Income | (256.7) | (207.7) | (201.1) | (171.3) | (212.3) | (374.1) | (10.4) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | 11.5 | 10.1 | 9.9 | 7.3 | — | — |
| Interest & Investment Income | 17.8 | 20.5 | 14.0 | 10.5 | — | — | — |
| Net Interest Expenses | — | — | — | (0.6) | — | — | — |
| EBT, Incl. Unusual Items | (249.4) | (195.7) | (232.9) | (176.1) | (217.0) | (381.0) | (10.7) |
| Income Tax Expense | 1.3 | 1.8 | 2.8 | (25.1) | (0.7) | 0.1 | 0.0 |
| Net Income | |||||||
| Net Income | (250.6) | (197.5) | (235.8) | (151.1) | (216.2) | (381.1) | (10.7) |
| Per Share | |||||||
| Basic EPS | (1.63) | (1.46) | (2.06) | (1.57) | (2.31) | (5.07) | — |
| Diluted EPS | (1.63) | (1.46) | (2.06) | (1.57) | (2.31) | (5.07) | — |
| Basic Weighted Avg Shares | 153.5 | 135.7 | 114.5 | 96.2 | 93.4 | 75.2 | — |
| Diluted Weighted Avg Shares | 153.5 | 135.7 | 114.5 | 96.2 | 93.4 | 75.2 | — |
| Supplemental | |||||||
| EBITDA | — | (206.8) | (200.1) | (170.5) | (212.1) | (374.1) | (10.4) |
| EBIT | (256.7) | (207.7) | (201.1) | (171.3) | (212.3) | (374.1) | (10.4) |
| Effective Tax Rate | -0.5% | — | — | 14.2% | 0.3% | -0.0% | 0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.